≡ Menu

Alzheimer’s disease vaccine study

Alzheimer's disease is one of those diseases that progresses over time. It robs one of their personhood and steals the memories of their lifetime. Estimates for the U.S. are that 4 million people suffer from this disease and that number is expected to double in the next 10 years. Nothing has been found to irradicate… Read More

Iraq contractors denied mental health benefits

A Los Angeles Times investigation reports that U.S. contractors working in Iraq and Afghanistan are often denied psychological injuries, like post-traumatic stress disorder (PTSD). Insurance companies fight psychological disability claims by calling into question the expertise of doctors who make such a diagnosis. An insurance psychiatrist specializing in pharmacological research denies psychology as "baloney." A… Read More

Pain Patch Recall

The Fentanyl pain patch has been recalled. The patch in question is the 25-microgram-per-hour patch with an expiration dates on or before December 2009. Currently it is a voluntary recall. Fentanyl is powerful narcotic that is opium derived and nearly 100 times stronger than morphine. Of the four main types of fentanyl in use today… Read More

Generic drug manufacturers say FDA’s new approval plan falls short

As the costs of health care continues to soar, consumers are looking for ways save money. As blockbuster drugs lose their patient protection, they are being manufactured by the major generic companies like: Teva Pharmaceutical, Barr Pharmaceuticals, Mylan Laboratories, Watson Pharmaceuticals, and Novartis. In an effort to increase the number of generic drugs available to… Read More

Declining memory linked to lack of imagination

When children imagine their future selves as astronauts, politicians, or superheroes they are using episodic memory. Episodic memory allows individuals to project themselves both backward and forward in subjective time. Creating an imaginary event, known as constructive-episodic-simulation, requires an individual to recall details of a previous experience and to put them together to create the… Read More

New guidelines for lower back treatment

After a thorough analysis of published research by investigators at the Oregon Evidence-Based Practice Center at Oregon Health & Science University, the American Pain Society and the American College of Physicians are set to issue new treatment guidelines for lower back treatment. With about 1 in 4 Americans experiencing lower back pain at least once… Read More

Obesity linked to Alzheimer’s disease

The Guardian reports that a major epidemic of Alzheimer's disease looms as the population matures and their waist lines expand. In the UK there are 700,000 people who suffer from dementia and most of those have Alzheimer's disease. In 15 to 20 years it is expected that over 1 million will be affected in the… Read More

Have you been misdiagnosed?

After a visit to the doctors office you want to believe that his or her diagnosis is accurate because it means you now have a path for recovery. The question is how often do doctors misdiagnose a patient's symptoms? The May issue of The American Journal of Medicine has a collection of articles relating to… Read More

Depression caused by childhood abuse may be linked to specific gene

People who have been abused as children and fortunate enough to carry a gene called corticotropin-releasing hormone receptor one (CRHR1) demonstrate less frequent depression than those abused as children who do not carry the gene. Rebekah Bradley, PhD, Atlanta Veterans Affairs Medical Center, and Elisabeth Binder, MD, PhD, Emory University, studied more than 470 adults… Read More

Two separate rheumatoid arthritis research groups have similar results

Researchers seek to identify the genes that make us susceptible to disease and illness. In two independent research projects, that searched the entire human genome for variants that increase risk of rheumatoid arthritis (RA), had remarkably similar results. The research was conducted at the Broad Institute of Harvard, in association with, Brigham and Woman's Hospital in the… Read More

Parkinson’s patients experience sleepiness & hallucinations

A new study may help predict which patients with early Parkinson's disease will experience hallucinations, sleepiness, or swelling. Identifying the risk factors may better guide which treatment is more suited for the patient, allow for earlier intervention and reduce disabilities, according to study author Dr. Keven Biglan, University of Rochester, NY. The 4-year study of… Read More

Fibromyalgia seen as a potential $2 billion market

Currently, over 20 drugs are in development for the treatment of fibromyalgia. That number is expected to grow in the next year. At present, the only drug to be approved for the treatment of fibromyalgia, by the FDA, is Lyrica. Sales of Lyrica are expected to reach $641 million in 2016 according the business forecasting… Read More